Basta 2005.
Study characteristics | |||
Patient sampling | Prospective study; sampling methods are unclear. This study also included women with endometrial and cervical cancer but data were reported separately | ||
Patient characteristics and setting | 39 women with vulval cancer FIGO stage I/II were included; number of groins was not reported. Number of midline/lateral lesions and tumour size was not reported Median age not reported Setting: a teaching hospital in Poland; enrolment period not reported |
||
Index tests | Tc‐99m and blue dye Histological methods included standard sections stained with H&E and IHC stains |
||
Target condition and reference standard(s) | TC: groin lymph node involvement RS: complete IFL |
||
Flow and timing | A total of 2.5 mCi Tc‐99m was injected peritumourally 14 to 18 hours pre‐operatively. 2 hours later, LSG was done. Blue dye (2 to 4 ml) was injected intra‐operatively 20 to 30 minutes before mapping SND and IFL were performed during the same operation Withdrawals, if any, were not described |
||
Comparative | |||
Notes | Limited details reported; no data per groin (requested 21 June 2013) | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | Unclear | ||
Unclear | Unclear | ||
DOMAIN 2: Index Test Test group | |||
Had the test operator performed 10 or more procedures? | Unclear | ||
Unclear | Low | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Unclear | Low | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Were other imaging tests performed prior to the index test to rule out groin lymph node metastases? | Unclear | ||
Unclear |